关键词: diabetes diet gastroparesis meta-analysis systematic review

Mesh : Humans Gastroparesis / diet therapy therapy etiology Gastric Emptying Blood Glucose / metabolism Diabetes Complications / diet therapy Randomized Controlled Trials as Topic Treatment Outcome Diabetes Mellitus / diet therapy

来  源:   DOI:10.3389/fendo.2024.1379398   PDF(Pubmed)

Abstract:
UNASSIGNED: Diabetic gastroparesis is a common complication in patient with diabetes. Dietary intervention has been widely used in the treatment of diabetic gastroparesis. The aim of this study is to evaluate the role of diet in the treatment of diabetic gastroparesis.
UNASSIGNED: This systematic review was conducted a comprehensive search of randomized controlled trials using dietary interventions for the treatment of diabetic gastroparesis up to 9 November 2023. The primary outcomes were gastric emptying time and clinical effect, while fasting blood glucose, 2-hour postprandial blood glucose and glycosylated hemoglobin were secondary outcomes. Data analysis was performed using RevMan 5.4 software, and publication bias test was performed using Stata 15.1 software.
UNASSIGNED: A total of 15 randomized controlled trials involving 1106 participants were included in this review. The results showed that patients with diabetic gastroparesis benefit from dietary interventions (whether personalized dietary care alone or personalized dietary care+routine dietary care). Compared with routine dietary care, personalized dietary care and personalized dietary care+routine dietary care can shorten the gastric emptying time, improve clinical efficacy, and reduce the level of fasting blood glucose, 2-hour postprandial blood glucose and glycosylated hemoglobin.
UNASSIGNED: Limited evidence suggests that dietary intervention can promote gastric emptying and stabilize blood glucose control in patients with diabetic gastroparesis. Dietary intervention has unique potential in the treatment of diabetic gastroparesis, and more high-quality randomized controlled trials are needed to further validate our research results.
UNASSIGNED: https://www.crd.york.ac.uk/prospero/, identifier CRD42023481621.
摘要:
糖尿病性胃轻瘫是糖尿病患者常见的并发症。饮食干预已广泛应用于糖尿病胃轻瘫的治疗。这项研究的目的是评估饮食在糖尿病性胃轻瘫治疗中的作用。
这项系统评价是对截至2023年11月9日使用饮食干预治疗糖尿病性胃轻瘫的随机对照试验进行的全面搜索。主要结果是胃排空时间和临床效果,而空腹血糖,餐后2小时血糖和糖化血红蛋白是次要结局。数据分析采用RevMan5.4软件,发表偏倚检验使用Stata15.1软件进行.
本综述共纳入15项随机对照试验,涉及1106名参与者。结果显示,糖尿病胃轻瘫患者受益于饮食干预(无论是单独个性化饮食护理还是个性化饮食护理+常规饮食护理)。与常规饮食护理相比,个性化饮食护理和个性化饮食护理+常规饮食护理可以缩短胃排空时间,提高临床疗效,降低空腹血糖水平,餐后2小时血糖和糖化血红蛋白。
有限的证据表明,饮食干预可以促进糖尿病胃轻瘫患者的胃排空和稳定血糖控制。饮食干预在糖尿病性胃轻瘫的治疗中具有独特的潜力,需要更多高质量的随机对照试验来进一步验证我们的研究结果.
https://www.crd.约克。AC.英国/普华永道/,标识符CRD42023481621。
公众号